Saiyed
Farid Saiyed, Colleyville, TX US
Patent application number | Description | Published |
---|---|---|
20130105636 | Rotor System Anti-Rotation Wear Protector | 05-02-2013 |
20140110525 | System and Method for Providing for Collective Control in an Aircraft - In accordance with one embodiment of the present disclosure, a trunnion includes a first portion and a second portion. The first portion is capable of coupling directly to a drive tube of an aircraft, wherein the drive tube is capable of rotating around a first axis. The second portion is capable of coupling to a swash plate of the aircraft, wherein the swash plate is capable of causing the pitch of at least one of a plurality of aircraft blades to change. | 04-24-2014 |
Sajid M. Saiyed, Eindhoven IN
Patent application number | Description | Published |
---|---|---|
20110016491 | METHOD AND APPARATUS FOR SELECTING ONE OF A PLURALITY OF VIDEO CHANNELS FOR VIEWINGS - One of a plurality of video channels is selected for viewing. A specific one of a plurality of video channels is bookmarked. An object representing said bookmarked channel is displayed. A displayed object is selected to select the bookmarked channel. | 01-20-2011 |
Shafi Saiyed, Lynnfield, MA US
Patent application number | Description | Published |
---|---|---|
20130093031 | SYSTEMS AND METHODS FOR AIR-RELEASE IN CAVITY PACKAGES - A housing for integrated devices that includes an air-release mechanism is disclosed. This is achieved, in various embodiments, by forming a vent hole in a package substrate, and arranging a package lid over the package substrate. The vent hole allows air to be released from within the cavity package, thereby ensuring that the package lid remains stably affixed to the package substrate despite increased temperatures during processing. The vent hole may be sealed upon mounting the package onto a mounting substrate. | 04-18-2013 |
Taslimarif Saiyed, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20140374630 | MICROFLUIDIC-BASED FLOW ANALYZER - The present disclosure is related to a microfluidic flow analyzer for pathological detection. The microfluidic flow analyzer comprises plurality of buffer channels, sample channel, central flow channel, plurality of exciting optical channels and plurality of receiving optical channels. The plurality of exciting optical channels and the plurality of receiving optical channels are placed at predetermined angle to the central flow channel. The plurality of exciting optical channels excite cell in the sample solution flowing through the central flow channel. The cell being excited produces one or more optical signals. The one or more optical signals are received by the plurality of receiving optical channels. The microfluidic flow analyzer comprises plurality of detectors placed on each of the plurality of receiving optical channels for detecting one of the one or more optical signals. The detected optical signal is sent to a computing unit for pathological detection. | 12-25-2014 |
Zainulabedin M. Saiyed, Miami, FL US
Patent application number | Description | Published |
---|---|---|
20110213193 | Magnetic Nanodelivery of Therapeutic Agents Across the Blood Brain Barrier - Liposomes comprising magnetic nanoparticles bound to one or more therapeutic agents are disclosed herein. Also disclosed are methods of delivering a therapeutic agent to a patient across the blood brain barrier using these liposomes, and optionally applying an external magnetic field. | 09-01-2011 |
20130136808 | PLANT-DERIVED FORMULATIONS FOR TREATMENT OF HIV - Disclosed herein are methods for treating mammals with HIV/AIDS comprising administering a therapeutically effective amount of a composition comprising an extract of | 05-30-2013 |
Zainulabedin M. Saiyed, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20150119335 | Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals - The present invention relates to a method of treating exercise-induced joint pain in arthritis-free mammals by the administration of undenatured Type II collagen. | 04-30-2015 |